4//SEC Filing
CardioVascular BioTherapeutics, Inc. 4
Accession 0001303497-05-000019
CIK 0001303497operating
Filed
Aug 17, 8:00 PM ET
Accepted
Aug 18, 8:14 PM ET
Size
8.3 KB
Accession
0001303497-05-000019
Insider Transaction Report
Form 4
ROTH VINCENT J
General Counsel
Transactions
- Award
Incentive Stock Option (Right to Buy)
2005-08-16$10.00/sh+11,000$110,000→ 11,000 totalExercise: $10.00From: 2008-12-20Exp: 2015-08-16→ Common Stock (11,000 underlying) - Award
Incentive Stock Option (Right to Buy)
2005-08-17$10.00/sh+4,000$40,000→ 15,000 totalExercise: $10.00From: 2005-08-17Exp: 2015-08-17→ Common Stock (4,000 underlying)
Footnotes (2)
- [F1]The option is exercisable ratably monthly over a four (4) year period commencing December 20, 2004 and shall be fully vested on December 20, 2008.
- [F2]Option grant pursuant to stock plan registered on Form S-8 and approved by the Board of Directors and thus such transaction, and purchases pursuant to exercise of this option, are exempt from Section 16b pursuant to Rule 16b-3(d)(1).
Documents
Issuer
CardioVascular BioTherapeutics, Inc.
CIK 0001303497
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001303497
Filing Metadata
- Form type
- 4
- Filed
- Aug 17, 8:00 PM ET
- Accepted
- Aug 18, 8:14 PM ET
- Size
- 8.3 KB